Sanara MedTech (SMTI) executive compensation, 2026 proxy

Seth D. Yon, President and Chief Executive Officer, was paid $2.3M in 2025.

Filed
April 17, 2026
Annual meeting
June 4, 2026
Pay year
2025
Named executives
5
CEO total pay
$2.3M2025
CEO pay in equity
57%$1.3M in awards
CEO Base Salary
$600,000Annualized under employment agreement
CEO Stock Awards
$1,318,742Grant date fair value for 2025
CEO Cash Bonus
$472,000Discretionary cash bonus earned

How Yon was paid

$2.3M in total for 2025, as reported in the Summary Compensation Table. Equity awards are valued at grant, not at what they turned out to be worth.

Salary21%Bonus20%Stock awards57%All other compensation2%

Named executive officers

ExecutiveTotal
Seth D. YonPresident and Chief Executive Officer$2,306,511
Ronald T. NixonFormer Chief Executive Officer$585,479
Elizabeth B. TaylorChief Financial Officer$637,054
Jacob A. WaldropChief Operating Officer$867,844
Suresh V. MuppallaFormer President and Chief Executive Officer of Tissue Health Plus, LLC$715,808

What changed and why

  • $2.3MSeth D. Yon was appointed President and Chief Executive Officer effective September 15, 2025, receiving total compensation of $2,306,511.
  • Ronald T. Nixon transitioned from Chief Executive Officer to Executive Chairman on September 15, 2025.
  • $637KElizabeth B. Taylor was appointed Chief Financial Officer effective January 15, 2025, with total compensation of $637,054.
  • Executive compensation consists of base salary, discretionary cash bonuses, and annual restricted stock awards.
  • 4%The company matches employee 401(k) contributions dollar-for-dollar on the first 4% of pre-tax earnings.

About this page

Figures are automated and can be wrong; check the filing for the exact numbers. Totals follow SEC rules, which value stock and option awards at grant. Read the DEF 14A proxy statement for footnotes and the compensation committee's full reasoning.